Market Currents
Goldman Sachs removes Baxter International (BAX) from its Conviction Buy List after finding...
-
Thursday, December 15, 2011, 8:54 AM ETGoldman Sachs removes Baxter International (BAX) from its Conviction Buy List after finding better opportunities in the healthcare sector. Analysts with the firm maintain their Buy rating, while clipping the price target on shares by a $1 to $59. Shares +0.4% premarket.
Other date
HEALTHCARE ETFs IN FOCUS
Latest Healthcare Articles
